Literature DB >> 27698784

OMP31 of Brucella melitensis 16M impairs the apoptosis of macrophages triggered by TNF-α.

Ke Zhang1, Hui Wang2, Fei Guo3, Li Yuan3, Wanjiang Zhang3, Yuanzhi Wang3, Chuangfu Chen4.   

Abstract

Outer membrane proteins (OMPs) of microorganisms play important roles in directly interacting with host cells. Brucella species inhibit the apoptosis of host cells to benefit their own intracellular survival and replication. However, the association between OMP31 of Brucella and host cell apoptosis, and the underlying mechanism are unclear. In this study, an OMP31 gene deletion mutant based on B. melitensis 16M was constructed. Following the infection of RAW264.7 cells with B. melitensis 16M or the mutant strain, colony formation, apoptosis, tumor necrosis factor (TNF)-α levels and the levels of key downstream factors of the apoptosis pathways triggered by TNF-α, namely caspase-3, -8 and -9, cytochrome c, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) were detected. The mutant strain was shown to have the same phenotype as the parent strain using traditional microbiological tests. However, the mutant strain had impaired intracellular survival, with higher levels of apoptosis and TNF-α expression in infected RAW164.7 macrophages than the parent strain. The downstream factors of apoptosis triggered by TNF-α, including increased caspase-8, -3 and -9, cytochrome c and Bax, and decreased Bcl-2, indicated that the classical and mitochondrial cell death pathways were involved. It may be concluded that OMP31 from Brucella inhibited apoptosis and benefitted the intracellular survival of this microorganism. Furthermore, TNF-α may have served as a switch triggering classical death and mitochondrial cell death pathways.

Entities:  

Keywords:  Brucella melitensis 16M; OMP31; apoptosis; tumor necrosis factor-α

Year:  2016        PMID: 27698784      PMCID: PMC5038375          DOI: 10.3892/etm.2016.3655

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  39 in total

Review 1.  Caspases--their role in apoptosis and other physiological processes as revealed by knock-out studies.

Authors:  Kenneth Sadowski-Debbing; Johannes F Coy; Walter Mier; Hubert Hug; Marek Los
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2002       Impact factor: 4.291

2.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

3.  Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c.

Authors:  T Rossé; R Olivier; L Monney; M Rager; S Conus; I Fellay; B Jansen; C Borner
Journal:  Nature       Date:  1998-01-29       Impact factor: 49.962

Review 4.  Brucellosis vaccines: past, present and future.

Authors:  Gerhardt G Schurig; Nammalwar Sriranganathan; Michael J Corbel
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

5.  Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis.

Authors:  L Monney; R Olivier; I Otter; B Jansen; G G Poirier; C Borner
Journal:  Eur J Biochem       Date:  1998-01-15

6.  Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein.

Authors:  N Vizcaíno; A Cloeckaert; M S Zygmunt; G Dubray
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

Review 7.  Brucellosis: a worldwide zoonosis.

Authors:  M L Boschiroli; V Foulongne; D O'Callaghan
Journal:  Curr Opin Microbiol       Date:  2001-02       Impact factor: 7.934

8.  Brucella abortus INTA2, a novel strain 19 (Delta)bp26::luc (Delta)bmp18 double mutant lacking drug resistance markers.

Authors:  Eleonora Campos; Silvio L Cravero; Laura Delgui; Inés Mora; Nancy Kahn; Alicia I Arese; Osvaldo L Rossetti
Journal:  Vet Microbiol       Date:  2002-06-05       Impact factor: 3.293

9.  Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway.

Authors:  G S Dbaibo; D K Perry; C J Gamard; R Platt; G G Poirier; L M Obeid; Y A Hannun
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

10.  Immune reactivity of Brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins.

Authors:  Amir Ghasemi; Mohammad Hossein Salari; Amir Hassan Zarnani; Mohammad Reza Pourmand; Hojat Ahmadi; Abbas Mirshafiey; Mahmood Jeddi-Tehrani
Journal:  Iran J Microbiol       Date:  2013-03
View more
  10 in total

1.  Omp31 of Brucella Inhibits NF-κB p65 Signaling Pathway by Inducing Autophagy in BV-2 Microglia.

Authors:  Zhao Wang; Guowei Wang; Yanbai Wang; Qiang Liu; Haining Li; Peng Xie; Zhenhai Wang
Journal:  Neurochem Res       Date:  2021-09-18       Impact factor: 3.996

2.  Brucella induces unfolded protein response and inflammatory response via GntR in alveolar macrophages.

Authors:  Dong Zhou; Fei-Jie Zhi; Mao-Zhen Qi; Fu-Rong Bai; Guangdong Zhang; Jun-Mei Li; Huan Liu; Hua-Tao Chen; Peng-Fei Lin; Ke-Qiong Tang; Wei Liu; Ya-Ping Jin; Ai-Hua Wang
Journal:  Oncotarget       Date:  2017-12-26

Review 3.  Dendritic cells and Brucella spp. interaction: the sentinel host and the stealthy pathogen.

Authors:  Eric Daniel Avila-Calderón; Leopoldo Flores-Romo; Witonsky Sharon; Luis Donis-Maturano; Miguel Angel Becerril-García; Ma Guadalupe Aguilera Arreola; Beatriz Arellano Reynoso; Francisco Suarez Güemes; Araceli Contreras-Rodríguez
Journal:  Folia Microbiol (Praha)       Date:  2019-02-19       Impact factor: 2.099

4.  The Immunogenicity of OMP31 Peptides and Its Protection Against Brucella melitensis Infection in Mice.

Authors:  Fengbo Zhang; Zhiwei Li; Bin Jia; Yuejie Zhu; Pan Pang; Chuntao Zhang; Jianbing Ding
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

5.  Astragalus polysaccharide strengthens the inflammatory and immune responses of Brucella suis S2-infected mice and macrophages.

Authors:  Qiwen Shi; Lan Zhao; Leifang Zhang
Journal:  Exp Ther Med       Date:  2019-10-07       Impact factor: 2.447

6.  Comparative proteomic analysis of outer membrane vesicles from Brucella suis, Brucella ovis, Brucella canis and Brucella neotomae.

Authors:  María Del Socorro Ruiz-Palma; Eric Daniel Avila-Calderón; Ma Guadalupe Aguilera-Arreola; Ahidé López-Merino; Enrico A Ruiz; María Del Rosario Morales-García; Edgar Oliver López-Villegas; Zulema Gomez-Lunar; Beatriz Arellano-Reynoso; Araceli Contreras-Rodríguez
Journal:  Arch Microbiol       Date:  2021-01-11       Impact factor: 2.552

Review 7.  Uncovering the Hidden Credentials of Brucella Virulence.

Authors:  R Martin Roop; Ian S Barton; Dariel Hopersberger; Daniel W Martin
Journal:  Microbiol Mol Biol Rev       Date:  2021-02-10       Impact factor: 11.056

8.  Brucella Downregulates Tumor Necrosis Factor-α to Promote Intracellular Survival via Omp25 Regulation of Different MicroRNAs in Porcine and Murine Macrophages.

Authors:  Xiaomao Luo; Xiujuan Zhang; Xingchen Wu; Xuefeng Yang; Cong Han; Zhengyu Wang; Qian Du; Xiaomin Zhao; Shan-Lu Liu; Dewen Tong; Yong Huang
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

9.  Mitochondrial fragmentation affects neither the sensitivity to TNFα-induced apoptosis of Brucella-infected cells nor the intracellular replication of the bacteria.

Authors:  Elodie Lobet; Kevin Willemart; Noëlle Ninane; Catherine Demazy; Jaroslaw Sedzicki; Christophe Lelubre; Xavier De Bolle; Patricia Renard; Martine Raes; Christoph Dehio; Jean-Jacques Letesson; Thierry Arnould
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

10.  Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma.

Authors:  Nancy S Younis; Amal M H Ghanim; Sameh Saber
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.